Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
Medical decisions are being made not only by insurance companies but also by hospital managers and algorithms, and concern for patient care continues to grow.
Medika has identified Vitaccess for our Healthcare Innovation watch list. This UK based Digital Startup offers innovative and exciting approaches to data management that directly benefit patient outcomes.
